Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지

The Differences of Circulating Adiponectin Levels and Multimerization According to Obesity in Type 2 Diabetes Mellitus of Men

제2형 남자 당뇨병환자에서 비만과 비비만에 따른 아디포넥틴의 혈중 농도와 다중결합체의 차이

Chang, Sang-Ah;Lee, Jung-Min;Sohn, Tae-Seo;Kwon, Hyuk-Sang;Son, Hyun-Shik;Yoon, Kun-Ho;Kim, Hee-Seung;Cha, Bong-Yun;Lee, Kwang-Woo;Son, Ho-Young
장상아;이정민;손태서;권혁상;손현식;윤건호;김희승;차봉연;이광우;손호영

  • Published : 20070500
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-5, 2001 https://doi.org/10.1210/jc.86.5.1930
  2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J,Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K,Muraguchi M, Ohmoto Y, funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin in obesity. Biochem Biophys Res Commun 257:79-83, 1999 https://doi.org/10.1006/bbrc.1999.0255
  3. Yang WS. Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CI, Tai TY, Chung LM: Weight reduction increases plasma levels of adipocyte-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metabo 96:3815-19, 2001
  4. Abbasi F, Chu JW, Lamendola C, Mclaughlin T. Hayden J, Reaven GM, Reaven PD: Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53:585-90, 2004 https://doi.org/10.2337/diabetes.53.3.585
  5. Waki H, Yamauchi T, Kamon J, Ito Y, Uckida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes. J Biol Chem 278:40352-63, 2003 https://doi.org/10.1074/jbc.M300365200
  6. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzshneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-62, 2004 https://doi.org/10.1074/jbc.M311113200
  7. Taso TS, Thomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuse JE, Lodish HF: Role of disulfide bonds in ACrp 30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278:50810-7, 2003 https://doi.org/10.1074/jbc.M309469200
  8. Chang SA, Kim HS, Yoon KH, Ko SH, Kwon HS, Kim SR, Lee WC, Yoo SJ, Son HS, Cha BY, Lee KW, Son HY, Kang SK: Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism 53:142-6, 2004 https://doi.org/10.1016/S0026-0495(03)00314-7
  9. 권혁상, 박용문, 이혜정, 이진희, 최윤희, 고승현, 이정민, 김성래, 강소영, 이원철, 안명숙, 노재홍, 강진모, 김동석, 윤건호, 차봉연, 이광우, 강성구, 손호영: 한국 성인에서의 NCEP-ATP III기준을 적용한 대사증후군 유병률과 임상적 특징. 내과학회지 68:359-68, 2005
  10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-9, 1985 https://doi.org/10.1007/BF00280883
  11. Kim MJ, Yoo KH, Park HS, Chung SM, Jin CJ, Lee Y, Shin YG, Chung CH: Plasma adiponectin and insulin resistance in Korean type 2 Diabetes mellitus. Yonsei Med J 46:42-50, 2005 https://doi.org/10.3349/ymj.2005.46.1.42
  12. 정혜승, 조영민, 김경원, 윤병수, 유강열, 박홍제, 신찬수, 김성연, 이홍규, 박경수: 인슐린저항성 개선제가 제2형 당뇨병환자의 Adipokine 농도에 미치는 영향. 당뇨 병 27:476-89, 2003
  13. Ferris WF, Naran NH, Crowther NJ, Rheeder P, Merwe LV, Chetty N: The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Norm Metab Res 37:695-701, 2005 https://doi.org/10.1055/s-2005-870580
  14. Hulver MA, Saleh O, MacDonald KG, Pories WJ, Barakat HA: Ethnic differences in adiponectin levels. Metabolism 53:1-3, 2004 https://doi.org/10.1016/j.metabol.2003.07.002
  15. Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J, Schaffler A: Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 454:103-4, 2003
  16. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-9, 2002 https://doi.org/10.1210/jc.87.6.2764
  17. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS: Serum adiponectin levels are inversely associated with central fat distribution and estrogen levels but are not directly regulated by acute fasting and leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88:4823-31, 2003 https://doi.org/10.1210/jc.2003-030214
  18. Huang KC, Chen CL, Chung LM, Ho SR, Tai TY, Yang WS: Plasma adiponectin levels and blood pressures in nondiabetic adolescents females. J Clin Endocrinol Metab 42:76-81, 2003
  19. Furuhashi M, Ura N, Higasshiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K: Blokcade renin-angiotensin system increases adiponectin concentration in patients with essential hypertension. Hypertension 42:76-81, 2003 https://doi.org/10.1161/01.HYP.0000078490.59735.6E
  20. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y: Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16:72-5, 2003 https://doi.org/10.1016/S0895-7061(02)03197-7
  21. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25:971-6, 2002 https://doi.org/10.2337/diacare.25.6.971
  22. Mallamaci F, Zocaali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T. Matsuzawa Y: Adiponectin in essential hypertension. J Nephrol 15:507-11, 2002
  23. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-69, 2003 https://doi.org/10.1007/s00125-003-1074-z
  24. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M: Mechanism of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 53:1621-9, 2004 [erratum in Diabetes 54:587, 2005
  25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki S, Eto K, Akanuma Y, FroguelP, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty acid-oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-95, 2002 https://doi.org/10.1038/nm788
  26. Lara-Castro C, Luo L, Wallace P, Klein R, Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55:249-59, 2006 https://doi.org/10.2337/diabetes.55.01.06.db05-1105
  27. Xu A, Chan KW, Hoo RLC, Wang Y, Tan KCB, Zhang J, Chen B, Lam MC, Tse C, Cooper GJS, Lam KSL: Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280:18073-80, 2005 https://doi.org/10.1074/jbc.M414231200
  28. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert M, Mohlig M, Pfeiffer A, Spranger J: Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54:2712-19, 2005 https://doi.org/10.2337/diabetes.54.9.2712
  29. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y: Androgen decrease plasma adiponectin, and insulin-sensitizing adipocyte -derived protein. Diabetes 51:2734-41, 2002 https://doi.org/10.2337/diabetes.51.9.2734